期刊文献+

抗人活化血小板嵌合单克隆抗体SZ-51/Hu的纯化、鉴定和核素标记 被引量:2

Purification,Characterization and Nuclide Labeling of A Chimeric McAb(SZ-51/Hu)Specific for Human Activated Platelets
下载PDF
导出
摘要 目的 评价抗人活化血小板嵌合单克隆抗体SZ - 5 1/Hu核素标记及其用于临床血栓放射免疫显像的可行性。方法 用免疫亲和层析法纯化SZ - 5 1/Hu ,并对其特性进行鉴定 ,以过量的 2 -亚氨硫醇预处理SZ - 5 1/Hu ,采用99Tcm-葡庚糖酸钠 (GH)配体交换法标记。薄层层析法测定标记物的放化纯度。制备实验性狗股动脉血栓模型后 ,经静脉注入99Tcm-SZ - 5 1/Hu进行SPECT显像。结果 纯化的SZ - 5 1/Hu分子量为 16 0kD ,亲和常数 5 .5 10 4× 10 8L/mol,每个活化血小板的结合位点数平均为 10 2 6 2± 2 372个。99Tcm 抗体的标记率达 96 %以上。实验性狗股动脉血栓模型注射99Tcm-SZ - 5 1/Hu后 4h血栓显示清晰。结论 SZ - 5 1/Hu保留了原鼠源单抗SZ- 5 1/Hu相同的活化血小板 (GMP - 140 )结合特异性和亲和力。99Tcm 标记后仍保持良好的体内特异性血栓定位能力 ,可望用于临床血栓放射免疫显像。 Objective To evaluate the mouse/human chimeric McAb SZ-51/Hu labeled with a nuclide and the feasibility of its application in radioimmunoimaging.Methods Purification of SZ-51/Hu was performed by affinity chromatography,and then its characteristics were analyzed.SZ-51/Hu was labeled by using the method of 2-iminothiolane modification and 99 Tc m -glucoheptonate(GH) transchelation.The radiochemical purity was determined by I.T.L.C-SG.The experimental formal arterial thrombus was prepared in canine,then 99 Tc m -SZ-51/Hu was injected intravenously and imaged by SPECT.Results The molecular weight of SZ-51/Hu was 160KD.Its affinity constant was 5.5104 ×10 8L/mol and the number of binding molecular of SZ-51/Hu in per sactivated platelet was 10262±2372.The labeling efficiency was more than 96%.The arterial thrombus was clearly discernible at 4 hours after injection of 99 Tc m -SZ-51/Hu in the canine experimental model of femoral arterial thrombosis.Conclusion SZ-51/Hu retains the similar binding characteristics in vitro and thrombus-targeting in vivo as that of murine McAb SZ-51.Therefore,SZ-51/Hu may be a potential agent for clinical diagnosis thrombotic disease.
作者 张玮 阮长耿
出处 《苏州医学院学报》 2001年第3期244-247,共4页 Acta Academiae Medicinae Suzhou
基金 国际原子能机构(IAEA)部分资助课题(CPR/06/02)
关键词 活化血小板 嵌合单克隆抗体 纯化 ^(99)Tc^(m) 标记 activated platelet chimeric McAb purification ^(99)Tc^(m) labelling
  • 相关文献

参考文献1

二级参考文献4

  • 1吴锦昌,中华核医学杂志,1994年,14卷,35页
  • 2吴锦昌,Nucl Med Commun,1993年,14卷,1088页
  • 3吴锦昌,中华核医学杂志,1993年,13卷,170页
  • 4阮长耿,血小板.基础与临床,1987年,88页

共引文献7

同被引文献14

  • 1李军,王世真,周前,张裕民.^(99m)Tc-人血丙种球蛋白的制备及其初步应用[J].中华核医学杂志,1994,14(1):25-27. 被引量:1
  • 2Frossard M, Fuchs I, Leitner JM, et al.Platelet function predicts myocardial damage in patients with acute myocardial infarction [ J ]. Circulation, 2004, 110 ( 1 ) : 1392 - 1397.
  • 3Gruff J, Klinkhardt U, Schini-Kerth VB, et al. Close relationship between the platelet activation marker CD62p and the granular release of platelet derived factor[ J]. Journal of Pharmacology & Experimental Therapeutics, 2002, 300 (3) :95 -97.
  • 4Coller BS. Platelet GP Ⅱb/Ⅲa antagonists : the first anti- integrin receptor therapeutics [ J ]. Clin Invest, 1997, 100 (11 Suppl) :57 -60.
  • 5Jackson SP, Yap CL, Anderson KE. Phosphoinositide 3-kinases and the regulation of platelet function[J]. Bioehem Soe Trans, 2004,32 ( 2 ):38.
  • 6de Cristofaro R,de Filippis V. Interaction of the 268-282 region of glycoprotein lbalpha with the heparin-binding site of thrombin inhibits the enzyme activation of factor Ⅷ[J].Biochemical Journal, 2003,373 ( 2 ) : 593 - 601.
  • 7Cierniewski CS, Niewiarowski S, Hershock D, et al. Quantitation and characterization of human platelet glycoprotein Ⅲa by radioimmunoassay [ J ]. Biochim Biophys Acta, 1987,924( 1 ) :216 - 24.
  • 8Ault KA. The clinical utility of flow cytometry in the study of platelets[J]. Semin Hamatol, 2001,38 ( 2 ):160 - 168.
  • 9Madersbacher S, Erger P. Antibodies and immunoassays [J].Methods, 2000,21 ( 1 ) :41 - 50.
  • 10阮长耿 杜晓平 万海英 等.抗人血小板膜糖蛋白Ⅲa单克隆抗体SZ-21的研究.中华医学杂志,1987,67(2):76-78.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部